CA2205104A1 - Device for incorporation and release of biologically active agents - Google Patents

Device for incorporation and release of biologically active agents

Info

Publication number
CA2205104A1
CA2205104A1 CA002205104A CA2205104A CA2205104A1 CA 2205104 A1 CA2205104 A1 CA 2205104A1 CA 002205104 A CA002205104 A CA 002205104A CA 2205104 A CA2205104 A CA 2205104A CA 2205104 A1 CA2205104 A1 CA 2205104A1
Authority
CA
Canada
Prior art keywords
thc
calcium
implantable device
biologically active
subjecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002205104A
Other languages
French (fr)
Inventor
Eugenia Ribeiro De Sousa Fidalgo Leitao
Joost Dick De Bruijn
Hai-Bo Wen
Klaas De Groot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chienna BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2205104A1 publication Critical patent/CA2205104A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/32Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30906Special external or bone-contacting surface, e.g. coating for improving bone ingrowth shot- sand- or grit-blasted
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00796Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/0097Coating or prosthesis-covering structure made of pharmaceutical products, e.g. antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00976Coating or prosthesis-covering structure made of proteins or of polypeptides, e.g. of bone morphogenic proteins BMP or of transforming growth factors TGF
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/18Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment

Abstract

The invention provides an implantable device coated with a layer of calcium phosphate and optionally one or more biologically active substances such as growth factors, lipis, (lipo)polysaccharides, hormones, proteins, antibiotics or cytostatics. The device can be obtained by a nanotechnology process comprising subjecting a substrate to a surface treatment until a surface roughness with an average peak distance (Ra value) between 10 and 1,000 nm and subjecting the roughened surface to precipitation of calcium phosphate from a solution containing calcium and phosphate ions with optional coprepitation of the biologically active substance.

Description

' HO4~ CA 0220S104 1997-05-22 Db~ceror ~nCOrpOra~ODiand relcase of blol~c~ly ac~e ~gcn~

The present invcntion ~elatcs lo i~ ~mpLaDtable devicc with a sjpecific sur~ace rwgbIle~ that hcilita~s in vi~o roll ~;on of 8 solution IP~diatcd co~tuy~ n ~e caldum ~r~ ,c, m w~ ic~a~r~lly iaccivc s ~:t: ~ s can bc copr~i-s tated. T~e prcscllt ;~r~ furthcr rcliates to a ~nocess of ~ .g suc~ a de~icc iandto the 1, ~ ' use of sucll a devicc.
US Patent 5,456,723 l YI ~es a~ ilnplant ~ a p~us ~netallic smface , ~vhichhas becn ~rcated by ~ e and ~Cli~._ acid etch~ng rcsulting in a sur~ace mi~o-r~uPhn~ SC ~g a .~ m~ pealc-to-vallcy height o~ about ~0 to 30 ~ d 0 a lou~l~nes; spaci~lg Of about 1-5 ,~m. The eA~ cly 6harp, comb-~ike ~Ct~lC ~S~sal~ m ordcr to achicve . rf;oP h~ si ~ bctwecn thc implant aIld the ~)ati~g matc~ial Q.y~ho~ti~) fonned on it by ~ g t~e L~L~A~a~Jditt m thc jm~p~nt A J~ of most L~J~o.~.~ite coatod l..~pl~ ~lc ~ that the ~ ~ of h ~ UA~d~itC oDtothC implant nequ~ ~ pn~ e ~ p~ sl whkh limit ~c oice of ~ e ~ c and result in higher p~ g c06ts. lnc ~ iol~ly e~.led tfrh i.l~.., for coatin~ implant mq~ with h~l,oJL~.p~t;te is plaslna ~3~5.1;" ~ (far a review, sec P. ~ ;ql~, in Hydrarylap~tite f~tir<~ in Ordl~poa~i~
Sl rgcry, Ed Gees~lc and Ma~ley, ~aven Pre6s ~Y, 1993, p~ 81-87). Anothcr dis-ad~ t~,~ of the plasma ~lep~ ~ tr h ~ e, iII afl~litinn to ~e hi~h temperaturcs ed, lesides in the rclatively la~gc particle size, m the ûrdCI of 30-7U ~D.
Ihe aim of the prcsellt inYention is to provide a coated i~p~t?~le dcvice that caD be uscd ;D a wide va~cty of b~ m~ plicatiolls (surgcry, bO~ C~ t-~t, y~ r~O~ S etc.). Thc devioe should g~e ise to effective boDc f~ orl and ~' 'I ;~~rly rcsult iJI a dcsired b.~o"i~A~ effcct, suc~ ssistlng bo~c fnnnAtion, 25 plG~-oti~g i..fi ~ l-n . or l~jjr~l jo~ dunng or after implantation, illduccd by thc ~5~ ~
of biCl~ y active sub5tances, such as protcins, grovvth-facto~, lipids, Qipo)poly-5~ lcs, cytostatic agcnts, ~.~io s) antibiotic~ or other biological agents. 1~
a de~ble coat~ng is ~ ~ d, degIadatio~ of said coatiDg due to solutioD Pledia~d p~ s or cdl m ~i-~d prOce6sGs s~ould result in a fi~cr e~,po~u.c or tcleasc of' 30 b;t~'~rJ~lly activc aven~. Thc ~IU~ r. of the device ~nd the t~ at which it ~s p~duced s~ould not have a~ adver~ cffect on t~c biological activity of sa~d agcnts.

~O41299 CA 02205104 1997-05-22 Thc aim is achievcd b~ a sbaped artide sllitablc as an implaDt of a solid, i.c.
noll-fluid, po~ous ~ non~ s matcnal ha~ing a su~ naDo r~Eh~ees, gi~ rise to thc ~-~inn of a composite coati~lg whcl~ plaoed ~~ t~;q Said solutio~sooDtaiD, but are ~ot li~ited to calcium and ~ e ion~, aud biologically active a~ents s (e.g pn)teiDs, grow~ cto~s, lipids, (lipo)~l~s?~ 5~ c~rt~l~tic agcllts, l~n~ 011~ 5~
A.~ I .;O~i~j a~d ~nay be s ~h--~l~ or 5;1. ~ w~t~ d, but may i~lso be rela~ely dilutcd.
The 0a~ng can lh~cr~c bc ~~--r d of both ~ orgauic phasc, such ias the biologtcally activc a~ent and an inorganic (c.g. calcium 1~'~~ ~) phase. lhe un;~ about thc plescnt L~llio~ is dlat b;l~lo~r~ y activc ag~nts cart bc 0 s~ i't~ ly co y~ ildted du~ g the f~m~r~ of dlc soludon ~n-' - d coating.
As a rcsult, a spt~ 1 arca in the coating or the whole Ih r~ of sa~d coati~g ca~be loa~ed with the biologically active agerlt(s), that cxpresses itsi use when c ~ or ,~lc-~scd at tbe surfacc. n~ ~ ~~ on the time at whicll the biolo~tcally activc agent is addod to thc ~l~ 'q eaid a~sent can be a~urately co ~ wbere Ih~ t tbe Ih rL~ ss of the co~ g, as thc coating f~ -- is a time-~ y.,/~ proc~s ande~ ;on o~ said agent f~om the solution rc6ults ~n thc formation of an ~o.~nic coatin~ (i.e. a cilaum p}l~.h~ coati~g). Utiliz:ing such a co-~ ~ip~ t~h~ C
wbere bir'~ 'ly aaiYc agents ca~ cither or not be co ylcC;~ h~ at L~,..i,lt timepoints and witJ~ ~;rr~ c~ r~ 1ion~, can rcsult in a wide vanety of coatin~s, from 20 lcilati~,ly simple e~;--~,c in whicb a hr~m~en~ c~nn~ tion of a 0 ~ ;p~ d biologiully activc a~ent is prescnt, to a vcry complex ooatiDg c~ inine, ar l;r~ e.~t le~els, ~irfe~llt co~ onc of L~ t ~ r~lly active agcnts.
Ihe 6urfsce rou~hness is an ;..,l~,t~ factos of the devioc according to the in~ention. Ihe sulfacc lO~ ghness is dcfme~ herein by the averagc pcak distance, i.e the~5 average spa~ng bchveen ~lo~Usiolls on the sud~ce (Ra value). This aversge pcak e c~n be 5h~ d e.g. b~r means of ~ ~ , FIPct~J~ b~ic o .~ (SEM). Ln general~ ~e average pcak dista~ce may be 1,000 mn or less, dawn to 10 mn. Thc mo~t suitable luuE)~Ilr- - de~cnds on thc nature of the materia~ of the article. F~ articles made of ti'~ u" the average peal~ distancc can bc e.g. ~om 10 to ~ or pol~uwic Inatcnal, thc ~,e$,~,d peak distance is ~om 20 to S00 Dm, .. hv,~s ~or ~ n1r~s steel the pa~k distancc is adv~nf~c~D~ y betwecn 50 and 1,00. 0 nm. In gcneral, thc ~,.vfe average pca~ r~ ~angc is between 2 an~ 500 ~n.

~041299 CA 02205104 1997-05-22 I

Ibe dcpth of thc 6urf~ce roughncss of the ~tidc is less ~tical th~m thc peak dis~ce. Il~ 4, a ~um depth is dec~able, in par~cular a pe~ heigbt - with ~espect to t~e doepest sitcs on thc s~ce - of at lcal;t 20 , up to ~bout 2,000 mn.
~ ~. f~"~ svcIage dcpth is of thc same order of ~hde 8~; the avera~c pcalc s~1 A~r~ and is in p0rt~ om 50 Dm to 1,000 . ~e B~erage depth caU also bc .1. s.~-l ;~A by means of Sca~ng F~ on ~;. .06cop~.
~hc ~-,~n~ of tbe impla~lt articlc can bc of various matc~ials. Ihese iDdud~
mctals, in pa~ticular bioc~mpatible metals such as titanium, tantalum, niobium, ~c~,.i.~ and alloys t~eof, as wcll as s~ c~ stecl. A~oUIcr usefill dass of bio-10co~patible matcrials compriscs or~amc natural and synt~etic ~ol~ as poly-ethylene, polypropylcne, pol~t~ h~n~)o~ h~len~ CIefloD~), whidl may also bc bio-deg~adable pol~ ,6 such ~s poly~l~coUc ~id, polylactic acid or ce~tain poly-~ -OGI~ 5 Ccramic matcrials sllch as calchlm phosphatc, ~ mirq or bioglq~, as well as ~ r~ ~ at~ials, can also be used as aD implant substrate. Thc ~ ] may bc 5pomus or ~ ~us. W~ere it is porous, thc pore6 arc disl;-~u~1 ~d ftom the valleys of the ~facc ~ue~-.-,sj by the deptb: i.c. ~e pores have d~pths sllbstantially greater fflan 2 ~ d thc su~face nDu~ may be ~ .r~ rnC~d on ~hc pore walls.
The ~!bS~h- havi lg t~e desircd ~urhce rough~ ~ss am ~rr~ bc coated ~n vi~ro with a laycr of a calcium I~h~,~e and one or more biologically aaive agcnts.
~IC C~ o- h~ coating caIl be relativdg ~i~, iD the order of froPI a e.g. ~0 nrn to 20U
m, especially &om 1 to S0 ~m. lhe calcium phosphate ~,~ f~ , foTms s~ crystals, .ing an - p}' D~6 likc strucmre. Thc calciurn phosphatc csn be any combination of calciun~ and phospbatc ior~, opt~ y bL,C_~h~ with c.g. h~dlu~idc, ch1or~
sulphate, n~tratc ctc. aDio~s or hy~i~.O- ~, sodium, p01t s;i~ , magnesium etc. cations. For 2sa fastcr process, the d~pa~-:' ;on step can be ~.,v~A~A by a ~ t ~ 1 stcp using a solution of calcium and phosphate ions, or two ~lyl;~...c c .-~ calcium ions and phosphate iolls ~a~ t;.vl~ and applied c~ - - - Jtivdy. The b;~ ' ~rs11y acti~e agc~t in the a)ating ;~ ,dFs, but is ~ot limited to, 6illgle or clJ ~ ;n~l6 of E~rotei~s, lipids~
Qipo)~d~s..~ides, g~owth-factors, ~ytr~ldlic agent~s, 1~ - s, ~d ~ ~; P~s.
30 E~amplcs of so~b agents ar bonc morphogcnctic protcin~ (BMP'6), basic ~ib.obl~st growth i~ctor (bFGE3, h~o ~n~, g~ factor ~GF~), ~ , nic g~h peptide (OGP), et cetera. Ihe r' ~ -' ~ ~ wcight of said biologically active agents call vary from B~D4~5q~ CA 0220S104 1997-OS-22 scvcral tens Of ~lto~c, tO i' ~ ~n~c of Idlo-Daltons.
The calc~um c~ating c~m be applied ~om a solutioD contaming calcium a~d pbo6phatc joDs ant one w mo~e dissolvcd biologically ac~e age~ts. I~c ~l~ may be saturatod w cvc~ supcr-satu~ated, but it may ~Iso be ~elatively dilutcd. This is an 5 ~ ~6~ Of tlle prcscnt il~ Sillcc it allows thc for~ation of a calcium phosp~ate coa~ng hom p¢actically a~ly solution c~ calcium a~-d ph~ io~~and tJe ~ '~F:-'IY activc agcnt. ~e pH n~D~e of thc cal~um phosphate ,....1_:..;,.,.
~olution may be bch veen 4 aIId ~0, ~ ti~l1y betwecD 6 aDd 8. The l~ad~g ~atc ofthc cwting w~ the bioloE~GIlly active ~gerlt(s) can va~y ~m several pn~milles to 60 0 pcrccnt (in wcight w1th rcspect to thc coating) and depcnds on the c~ ti ~whic~ it ~..~ its biololpcal activjty. ~bis a~ bc esl~blisJ~d by va~y~ng thc " ..~ation of ~e biologically activc age~t in the ~Illho~ he ~ ;t~ coabng canbe ~,u.l~,~J to dc~rsde due to solution ~ d or cell mediated l~lo~ s, or can be ~,G~d as a sbble coa~g that shows littlc or no dcgra~htion.
lS Ihe ;~ Jt~ hlc dcvioe unth the calcium phosp~ate ~nd biologically active agent w--~ e coating can give rise to the ~r~ c~h~ e- ~ or; A~JC ~ of e formation when implanted wben thc ~iolo~ir~ly active agcnt is co-~ d of an ,a ~ ' tive protein, c~ gtowth faaors.
Thc ;~l~v.~tion also ~vvides a process of pl~Cil~ a dcvice as d~ d abovc, b~t sub~ecting a solid matcrial to a suIface 1-- 't"" ~~1 U~ a ~urface roughncsswith thc ~ u---,d avera~e peak distance (R8 value) iS ~l3t, ~ d, and L ;~, -ntly coating thc dcvice with calcium ph~rh~e, o~t;nr-'ly tOO~ with a biologically acltive sub6taDce.
Ihe ~ 1 may e.g. bc a sanding or ~coring treatment USiDg z5 con~ tiol.al sa~paper, cmery papcr or glass paper havin~ an applul,l~t~, fincness, e.g.
grade 4000, optinn~lly i~ the ~ CG of.watcr or oth-r fluid6. Diamond paste can also bc uscd in t~e ~--- h~ 1 surface t--~U---- ~ Ihe sur~ace ro~Jg~ r~ can fu~her bc,d by powder ~ nr u6in~ç suitablc fine pu..d~,,s. I~e surface roughI~ess may also bc ~ by a ~ h~ ....f_l 1 -- ~' ~- with a strong, ~ v~bl~ mmeral, a¢id sol ~tinn~
30 optinn~lly follanved by ~ n~ agents sucll as hydrogen IJC. u~;~, optioDally followud by hcu'Q~ g steps.
rne coated i..~p1-p"t~1)le devices ~co.di~ to the ~ tiol. are ~~n('~' for -' BO4~g CA 02205104 1997-05-22 bi~P~ir~t use, i.e. as a bonc subs~tute, a joint p,.~ . s~6, a dc~t~l impla~t (~
dontics), a ~-11c'- ~ ' ~plant, a ~ ' surgG~ d, a t~ .,t~ device (stoma a~d thc lilce) and othcr mcdical or CPC'~ ~ de~ a~ scrve a6 a bone ~P,nt ar ~e ~ l, but also a~i a mea~ f ~, a de~ice to a pa~ticular s bone.
EXAMPIE 1.

Ti-6Al~V alld rl-Al-2 SPe samples, 9.15 mm a~d 5 mr~ in diameter ~spec~cly and 1.~ mm thick, werc used. They wcre ground ~at in SiC pap~s, 1200, 4000 grit a~d o ~ poli~hed down to 1 ,um. 316~ P-- steel ;amples, ca. 80 mm~, were also g~nd iD SiC pape~s, 120~ and 4~00 g~it. All samples were ~ ;r_11y cleal~cd u~
~0~0 ethanol for 20 ~ utes followed by a ~û-minute doublc nPSC with d~stilled watcr and dried under a nOw of hot air. The s~ ~o~g' . ~: ~ wcre meas~ed with a laser ~rfi'l~Pt~r (Eerlcin Elmcr). Tablc 1 show~. t~.e results of the following ~o~n~c ~s paramete~s: Ra - aLi~h ~'~;~ m~ of thc ~ ,s~ hd~çht, ~z - mean pcak-t~v.dley hei~ht and Rma,~ o ~ n~ s~ depth.
~ftcr surfa_c ~li~J ~ d ck~ ;~ all saD~plcs werc ;~ --"s~. in HBSS at 37~C f~r 14 days in ~ep~T.~te pol~ lc~.e ~ 't~~ To allow a ~ .~pply of sn~tinn this was ch~ ~A every 48 hou~s. Empty pol~ Icll_ n~ V~ s we~e used as rcfere~oe. A
zo c~mple of ea~ l~h;e~d s.olution was stored iD 2 mL F,~ .. t~T at 4~~. Ca and P
concent.~ations ill d~cse 8~1L~ r ~ u~ by atomic 7.~s~ t;~ sp~hO
met~ (Yarian SpectAA 300) and 6~~:t,s~ 0.. t~ (Vitalab 21, ~italab ~ t;fic), ~w~i~d~r. All the Iesults are the avera~e of at least three ~ t~.
All su~r~s ~Ivere obs~"~, befose alld after ;~ o~ by sC~nT1ilu dectIon micro-25 scopy (Philips SE~ 52~ and analysed by XR~ oyager X~MA syste~ NOR~N
I~struments): X~D OE'bilips ll~-film XRD) ~as u~ed to d(t~ , the ~u~ of the y~ te la~ APM was used to.obselve its ~n~ h~logy o~l pnl;~h,tl t;~ . "

alloys.
Res~ts ~ discussion 30 Pig. 1 ~hows t~e Ca c~ ltratio~s as a L- ~in,~ of time. 1~ the sv'~ ~ir - that we~c in c~tact ~ith the alloys, a ~ oun~ ;C dccrcasc of tbe c~ tinn~ of Ca was cl~ h~ ~- A
The samc ~ v ol~ was also obs~ d for the lr~ e~ SS. Until day 5 all aurves _ave similar fo~ms b-lt aftcr day S a highe~ d~sL f~r the 1~-6Al-4V 1 ~ ~ s ,t which ~ cs 123 ~1.5 ppm. ~or both Ti-6AI-4V 4000 a~d r~ 25Fc ampks thc Ca ~ A' ation ~ ai~ d more rapitly aftcr day 7 ;~ttaining similar final C:a upt~ko co ~ ations, 61 2.3 and 63-1.5 ppm"~~ . All othe~ r~ s , e~bited Ca upl~e values ~t~ 5 alld 20 ppm.
S ~Ig. 2 thows the P L ~r ~tio~ ~s a filn~i~ of ~me. Thc P uptake culvcs, li~e the Ca ;01~6, al~o showed a ~cc,~ as a F~ r.l on of timc. I~c r~-6AI-4V 4000 a~d 1 llm and thc ~-Al-25Fc 1 llm shawed thc highess P uptakc; 29 ~2~1, 34+1.S ant 58 ~ ~ ~ 7 ppm, ~ . Thcsc findings suggcst that a Ca and P ric~ } ~ isformed ou all the sur~ ~m thc HBSS. In fact, it was possible to seo a white fiL~lO ~ thc pol~ k~c, tbat coJItactcd ~nth thc ~SS. rl--Al--25Fc 4000 and 1~0 showed the lowest Ca and P uptake. rrhe decl ~- ~ ~ in both C:a and P w~ ~ lt~ A
to the gro~ ~f p~ -;p"~'~ nuclei on the su~faces f~m thc HBSS sol~io~l Similar b~ho~r;u~ was fou~d by Ii er a~ [4] after i.. -,,sio~ of silica-gel and gcl-dc~ived titania il~ a ~im~ ed Body Fluid; ~adin e~ a~ 12] also lcl,oll~.d a decrcase in Ca and 15 P ~ dljO~ sS5d Ph~;c'D~ Sol~lbr~n after the immcr~on of cersmic Fig. 3 shaws SEM ~ o ~;~Ao~-aphs of tbe metal s~ ces after immersion i~ HBSS.
~n~ ;np t~c ph~t~ on Fig. 3 it can be seen tbat the l~ t~ layer has a platc mc p~ ,y on which "~obl~les" and/or crystals grow. ~A rcvealed a higher 20 qud.ltil~ of Ca and P on these palticles tban m the plate 1~ c;~ It was t~ ' l to obse~ve that thc plates Laclu.~d on some of ~e clllf,-~5, namcly Ti-6Al-4V 1200 and 1 llm, h-AI-~.SFe 1 ~n and s~ lPss ~teel 1;~ hc o~ ~ of the rr~ .,s docs not secm to depend ~n the (~prts~j~ of t~e ~ntling fl~ws as it is "csi:~k to obser~e a ra~dom c~-~ L ;-,4 of the plates. The ~ ate formed on Ti-~1-4V 40ûO ~hows a ous te~e at the 6a~e n~aS~ ni as thc othcr O~ dlions. It was only possl~le to detcct L~s OD thcse ~ 6 On thc Ca and P rich layer, at ~,.~.. r;.~,.. ~ higher than 2400 x.
Ii et al. [4] p-~fo~) ~ a series of ,~.J).~ t~ in which silica-gd was i..~ $-,d in S~F Ihey suggest t~at the lr~ inn of apatite growth is relatcd to thc Ca/P molar ~atio 30 o~ the fluids. F~.~,u.h;-u e~ a~ [1] obtained .I;r~ HA ..~ h~ci~s b~ p Fc and 15 in Ca(cdta)2~-~aH2PO4 s~lutinn Vanous ~v-~r "~t~5 of Ca(edta)~ had a direct effcct on the mo~phology of the L~LuA~aydtil~ film.
Ihe SEM o~,v~ions s~ggest tbat the ~o~bol~~y of thc ~lL.,;~i~tC lay~ seems to be~iu.n~ both on ~ ~ l and surface fi~i5~in~ as thc i~ ,r.ri~n fluid was the salDe ~ .lD9 CA 02205104 1997-05-22 in all ~
Pig. 4 sbows an AFM photo.ui~ rh ~om a 1~ 1-25E~c 1 llm sample. It is ~p~ t tl~ thc calaum phosp~ate ~iC]l c~atin~ is con6titutcd by the ~ ,sbon of sphcrical particles. Simila~ r~sults ~Ivere dlt'~ F~3 fo5 thc Ti-6AI-4~ ~ - r ~-,S. It soemS that s t}~c F~ of tbc coatin~ starts with h~,t~ ic- of nuclci ~vhi~h gathcr with time unh1 all the su~face ~s cove~d.
It was nDt;c~ that t~e r~ 2~sFe allo~ surf~c6 4000 a~d 1~00 did not e~hibit plate pqccipitates. lt w~s only possl~le to obse~vc small scatteret dçposi~s which had a umilar ,..n.yh- I~l!Y to c~ystals. ~RMA a~is~ on the nat g~o~ howed 0 thc presence of no Ca or P. The 6amC ar~ ;t jn OII the ay6tals showed the ~ ~ .t e of t~e alloy clr....~ 1s, ~a ;md P, associatcd ~vith Si. Si sccms to act as a Ducleus for ~e prcdpitatio~ and ~h of the c~ystals. Th~6 illl~JUlit~l k probably dne to thc SiC cmcry paper used duI~ng thc ~ur~acc J _. atiO.,. Eithcr the d~ .g and cle~ L of thc su~c~ was not sufficieDt, oll thcsc s~f~rs, to ~:move the SiC or somc SiC particles 15 might be ancho~d in the alloy's surfacc as ri-~-2.s~ is a softcT matcrial than thc otber allo~s.
Fig. 5 e~hibits ~RMA spectra ac4ui..,d ~D a IS-6AI~V 40W 6ample ~cfa~c a~d afteron in HBSS. Ol~e can obsave the 1~ v c of the alloy el~ e ~ as weU as ve~y well dcfilled Ca ~d P pea~ on thc aftc~ he r7~ S't~ atio iS 1.56~0.03 which ;- ~ t~s that tbe ~ r~ pluWI~. consists mainly of tncalcium l.h~SI,}, ~1A
F1g. 6 shows ~ spect~a ~cquilcd o~ non~ d (A) and ;~
4V 1 ,~ ff On the: ~ v.~,d samples ope can observe the arp~ of a well defincd [002] peal~ d a broader peak which seems to be ~ ;L,I-,d by the jun~uo~J~s of pea~ [211] aDd [112] indicat~ng the as~o.~hous c~ n~ s of t~c calcium Jh~,h ~te. Thcse rcsults suggest that thc ple~ipitate laye~ has an 9~ *C~l:c apatite-like ~hu~lu.~. S~lar ~SultS werc ~ajn~ for thc Ti-Al-25Pe 1 ,um sa~Dples.
Tllc ~ hIf ~r of this layer was prcviously d~te~Inincd by SEM obsc"-~io~s and is ca.
5 ~Im. Ii ct al. E4] I -o~t~l~,d tbe d~Io~ --- ")t of h~u~apalilc ~l~tc 011 gel-denved 30 titania, as a r-,.. ~;o., of time, after - - - in ~ Body Fluid. 11l the ini~al stages thcy d t~ . d precipihteS all Over the suIfacc wbi~h in~ - - - ' in numbcr snd si~ until, e.~ t~ 'Iy, all the su~face wa6 covcrcd by a lO l~m coating. D~ ,.c etal. ~ c~Jo-ted the r~l f~t;o - of small dcposits on titanium discs aftcr 1-day CA~U~C;
toaS ~ 9t~ ~lSollltjnn l'wo wecksof.lifr."~ ti~ wcrcnccded ~0 41299 CA 02205104 1997-05-22 to ~,.~c~ an apatite laycr wi~ a ~ C_ of 1 ,um.
~imawa et ~ 13] ~lso IL~ A that apatitc is ~mlly fonncd on tit~ wbe titanium i6 i~ d m a solu~on whose pH is similar to ~at of tbc ~ rid Ihey b d a Ih~ of 7 ~n of t~c apatitc f;lm grown on 1~ 4V wllicb make~ it s impo5siblc for this laycr to e~hib* ;Iny ~r ~ s of cal~um ~ e in this en~mllcnt. ~-The pra;e~t ~rsults iDdicate that a calcium phosphate with a~ atite-l~e ~hu.l~..c is nah~a~y foImed ~ the surfaccs of ~olisl~ A ti~ m alloys. Thc Ih;- L ~-- P~ of tbis laye~
n~alces it a suitable ~ce for bone ~udu~lio~ ~rs~es of at least 1 ~ re needed 0 for thc calcillm phosphate to show its p.uç~ 1; s a~d cause bonc ;,,-~ ,, [51, Concl~lls The mo.~ y of calcium ~h~ t~ s depends on the metal DV~ t~ and its s~acc ~ h ~; ~cs It is possible to pro~ce a naturally formcd calcium phosphatc coatmg by ;.. -.~ P metsls such ~ titanium alloys and ~I-;'fl~SS steel iII HBSS.
S Ti-6Al-4V 4000 secms to bc thc surhce that is most f~vvu~ ~'e to producc a ~..1;...~..C and more "~ t apatitc-liXc costiDg capable of bone . ~ ;o E~XAMPLE2. Deter~iDation of cah~u~ pho, b7 dept~ dist~ibuffon on a titaDium al10~ subst~te uslug x-~y ~ nt~ ~! f~tron spectroscopy Ihis e . m~ '- illustIates the ~rt~ tion of thc dcpth ~ j~h il /l~1 ;o~s of selected ~ s ~o iD a ~r - n rh~ k~ous and oxya~ c~ E! coatiDg on a ti1- ~ alloy sample using deplh rrt-filin~ X-ray PhOlOGlG~Ilo.. S~lu~ XPS o~ ~SCA).
Mat~rials The s~n~plPc were titanium alloy plates that had becn surfacc ~ated ~cro,d~ , to the of E~ca~ple 1 to p~ducc a calcium pho phate co~llg when . . . ~s d in 25 cal~ ;r;- 1~;t~" 501 ~icr. or simulated body fluid~ c samples we~c ..ou~ ectly to a ~ PS sample holde~ usi~ a spnng clip -~ ~ge~çnt~ with no p~e~l~ t Ihe outc~ coa~g surface was ~ r;~ y r1r~h;~ y co~A~ 1J~ that no clc~l~ldtic char~ing ".~b'~ - were encountacd durine X-ray ;~t~ tioo or ion beam ctchin~. All analy6is we~c camed out using a Su~face Sciencc ~t~u.,.c~ts (SSI) ~ ~lobL o~ .~tioP
30 ata b~ J.e~ e of 3~10-~ taIr.
M~thods A s~c~r ~ wss .~,co.~i ~om tbe "as ~;v~l surface, to d~,t~ , the surfaoe c~ ~si1 io~ o~ e co~ting and ll~.crol~ ~h t~, ... ;. .-, the elr~n~ to bc Aloni~ ed B0~1299 CA 02205104 1997-05-22 for ~hc depth profilc. Ihe XPS depth profile was o~ by -'t-~ ; argon ion sF ~ ring (ovcr an area of apprm. 2 ~ 2 m~n) and data ~rr~ ;n~ om an aIea of aRra~. 300 ~lm ~ -,tt.r oe~ ~ etchcd crater). ~ ts aDal~ed ~erc c~rbon, o~ cD, calcium, phosphoms, magncsil~m a~d ~dtaniu~. Etcl~ time per step was vaqiablc s f~om 15 to 120 seco~ds pcr qrcle and t~e etch ratc was 3 mnhnin using a total sputtcr time of 4470 ~r~
R~su~
~e surf~ce cbemical ~ ;OI~ (~ atomic pc~t) of the "as ,~;~ 1 ooating was:
car~on 44.99~, o~ygen 33.8%, calcillm 10.5%, ph~y~ ,us 8.8%, n~ ... 2.0%
0 and t;~ -- 0% (figurc 7). Ibe depth p~ofilc of thc coating lC~ a gradual t~a~sitio~ of cslcium aDd ~br ~ ~u from thc coating to thc svb~ dicd~ g thc tion of these elcmen~ in the surfaoe (~dc layer), aDd thu~ a ~ .,~ t bnn~i-tg ~ ~n coating and ~ tc (figurc 8). The ~alcium - o~ygcn - ~hn~ ous laye~
(calc:iu~n phosphatc) is ~ as bcing 9~ r ~~ PJy 90 nm~ "~~'"";~C a sputt~r ratc S of 3 nm pcr minute as ~~ on a t~ IO~ f film on t9rltS~ d that the "interface" ~s defin_d as the point whcrc the ~ m re~ches approx. 50% of its final value. A thin layer of ti~ .: .. oxide S~-.~ thc calcium ~Qq~h~ lay~ from thc t;t~rJ; ~ alloy SUti~hat~' Tbc j~t~..fs~. betvveen t~e cal~ium phl~c~ .- and li~-.;..n~
shows chaDges in the o~ygen, ~hc~ olls, c~lcium and l;~ Cl~e S~ Thc XPS
20 pealc bind~ ~-- ~vs of calciu~ and rhn~ph~ous d~ea~c at thc interface ~n~h the .;.. whe~e a ~ ., o~ide layer is found. An Intt,~ region is likely to oocur at the bou~,d~y and o~ygcn has been d Llet~ ~om t~e calcium ~ pk~1~ to form tj~ - dio~ide at the interface. hl~tallj~ titanium is present below the region. ~ is d~,tec~ at 2 - 4 atomic pcrcent ~hlou~hout t~e calaum pho6phatc ~5 layer aDd i~ slightly in cn~ .. with depth towards thc interface with the t;~ ide). Carbon is found in tbc bulk of the tit~i~m rDriCi-lSi The calcium phospbate layer that is folmed on the titaui~ alloy ~ is fl ~ " ~_lly bound to thc s~ - via it6 surface oside laycr 30 E:~AMPlE 3. Prepamtion of biomimetic c~lclum phosphate coatings on metallic implants and co precipibtion of proteins This c ~u~ C illu~trates a new tw~step ch~ raJ treatmcnt for p~epanng an implantw~t_ a specific sur~ce lu-.J-~ , resultin~ in a met:~ic surface that allows k~t ~041299 CA 02205104 1997-05-22 of bi, m~ calcium ~ e (Ca--P) coat~ngs from i/l vi~o sa~ated c~ in~ 601~liO.-r (SCS). Tbc presen~ method bas the ~dlowiIIg adva~ages over tbe ~.I._~;o~ u~c for the ooa~g a~ ;nn- tuc to thc 6pccific su~ e b: im~t-r CO~ ectly inducod ~om SCS arc s ~ t~,d to bc c~ ;c~lly bound to metallic 6~1~t 1 5 a~d to ~ow bi~her bone-bonding ability, (ii) tbe ~ ca~ be y ~ /o~ onto CO~Dpla~ F' 9~ md~or maa~
p~ imp~ d (~) it i~ a coD~ollablc alld cost~E~li-,_ way to acq~ C~a-P
coatillgs. To ~ thc pot~Si9~ of bi~ he calcium phospbatc coatings as drug-nclcase r~ p~> bovine se~um ~Ibumin (BSA) aDd Ca-P ..~..~ we~c co ~itated 0 on tbc trated ~ " -- s...r~ by immcrsi~ in the SCS ~ , 0~% wt. BSA
The BSA/Ca-P coa~ i are ~ c~l~ to 6e~vc as a pOh.~ Irug-relcase systcm.
Matcru~ls and Mcthods A ncwly dcvcloped two-~tep chemical ~ ~Ga~ c ~l w~ ~,fo,~ d on thc mctallic implant matcrials, ie. comme~ally p~re btanium (cp.T~ al~d Ti6A14V and pOIIOUS
5 tantalum CIa), to p~duce a s~ific surface r~l~n~sC. Du~i~g ~is t~catment, two sene6 Of .1~ ,C.It~ were used for titanium (cp.Ti and Ti6A14V) and ~ Dplant~atenals, ~ , t~at ~sulted in ~e ~ r of thc specific s~lrfacc roughness o~rc~ for the ~ ?,tio~ of thc coating. For the f~mcr, the samples -w~e t~eatod with a mi~hrc of ~Cl and H2S04, followed by '~ Q in a NaO~I sol~ ~ior~, Tbe 20 ~s l~ samples vvere treated ~th a mi~ctwe of Ha, H2S04 and E~, followcd by i---- ~ in Hz02.
~wo kinds of SCSs with J;~c~t Ca a~ld P coa~ , fast calfifir~tjl~n s~ tinn ~CS) and w~ uuv.ci~l Hanks' ~~ r~ salt solubon (HBSS), wcrc uscd for p~paring eti~ P rr~ To ~,o~otc tl~ Ca-P n~ n o~ the m~t~ c~ $,~S a p~ecalc;r;~ Ca) p,~ - c was performcd o~ half t~c trcatcd samplcs bcforc -- ~io~ ill the SCS. The Prv-C~ was ca~ried out by in~ubati~ the ~nplcs ~n 05N
~a2HPO4 o.~ ht and tben t~ v fr l; g them into saturated Ca(OH)2 for 5 h. The rolution for eo p~ ;pit~ n of BSA ~nd G-P eoati~gs ~vas ~ o;v~g 0.2g6wt. BSA into FCS. Thc u~ metals wcre also i",....,,s~ as 0lltrols. Ibe FY~S30 solution vol~me used for ir..~ was 1~ ml per cm2 of sample surf~oe aTea. The samplcs w~c i- --~ in scalcd ~ sl~ vials at 37~C ~n a e~lihmtcd ~atcr-bath ~ g C~ n.icl~, (SEM) togcther with cncrgy ~~ X-r~y (ED~) analy~es, X-ray dif~raction (XRD) and in~ared (I~) ~tlvl!hr~ t.~ we~ used to ch~P~i7r the oL~ Ca-P coat~ C

Ibe biamimctic Ca-P coa~ngs were fast preapitatcd on thc ~eated cp.n and Ti6A14Vsamples by ~ in both F~S and HI~SS no mattcr ~.hclh.,. the ~Ca pl~lh.e WaS p' f~ or ~t. But thc ~ ould ~b-~ lly ~pccd-up thc 5 prec~ta~on ratc of the Ca-P ooatin~s as listed in tablc ~
Figurc 9 shows that a bi~etic Ca-P coatiDg, a~o~' ately 16 ~ k, was fonned oll treated cp.Ti aftcr 16 hou~ of :~v~ in FCS with Pre-G. The coat~g got thicker wid~ . t~me as iudicated by EDX (figure 10) a~ld XRD (figure 11) ~sults. I~e ~",e.-~it~ ate of ~e Ca-P co~ng in BSS is dowcr than that m FCS
lO Blt ~c caati~g ~m HBSS (f~u~e 12) was m~ch dcnscr than that ~om FCS. Thc coat~ng from HBSS mainly e- ~ ~~ d of apatitc (figurc 13). Bio~imetic Ca-P :4 ~t~
could also bc ~ cip~ on porous ra samples (figurc 14) after the ~eatme~t. Thc surf~e contcnt ~hange of the sample w;~s ~tcd by E~X as show~ in figurc 15 It isro~ that no ~ .iQ~ was ob~c~ d on any ulltreated samplcs after 2 weeks s of ;~ .e.si~ F~S or ~IBSS, even u~i~ Pre-Ca. Ihe f~". ,t;~" Of a spccific tit~a~d t7~RlU-rl onde la~er after thcir trcatmcnts is p.ob~bly thc m~n reas~m for the i~i~., pl~ ti~lJ of Ca-P coatin~s by meaDs of in vitro ;---u~ in SCS. The ~, vc~l~c of the t~ n~tc for tit~ m impl-~lts ~nd t~r~t~lll~ could not bc ~ ~h~ ~g~-d ~h~w~ ~ no Ca-P coatin~ was ~ui,~d. It is i~t-,.c;,.".~, to find that thc rcsults of co-,c~ ~'in~l Of BSA and Ca-P coatmg we~e positivc. The iR a,~ Jrs (figurc 16) ind1cated thc obvious ~ r~ of BSA in the Ca-P coating oql cp.Ti aftcr ~,-- .-:
in F~S. Relcase e ~of BSA from BSA/Ca-P coatings are ~i~d in Example 4.
Conclusior s Thc ~esults of this b;~ ~ calau3~ ~s~lk ~ coating and protein co p,~ .it ;~
stuty have show~ that:-. The ~e vly d-,~,lo~d t~o-step rh-omir~l t~ is an cff~;~ mcthod to prcparc bioact~ve m~t~llic ~ t s~ g f~t ~ Iy ~ - of a~ Gllt b~
Ca-P c~';~,s by L~l vi~o immersion in SCS. IhG chcmical ~agellts pccdcd for ~c ~ of ~ nplant m~ c and tantalum are dirr~ om ~ othcr.
. rpe prccipitation of C~-P c~dti~,Es could be ~ ly ~ cd by mcan~ of pIe-calcifyin~ thc trcated samples bcfor~ thc i~ion .
. I~e ~ io~ latc and c~ u~ -- of the Ca--P C07'~S Can be, 1~: d by cont~lling thc cv ~ n~ ~ of the SCSs (FCS or HBSS) for ~ e.~

1~

. Somc p~ lL~e BSA can be co p~ d w~th bio ~ ;f Ca-P coatill~s. Such composiSe ooatings, with other - bioactive - - 1~ ,1~1 ~c molecul~ t~
to be able so scn~e as pot~t~sl ~Lug ~ systems.
EXAMrlE 4. Rel~se OI Bo~i~c Senlm Albumi~ tB~) f~om calclum p ~ -(Ca_P~lBSA ~flt:r~g~ on sur~ace-treate~ commercially pun~ titanium Co ,Iccip*~io~ orBS4 Coq~mucially ~ lqr blocks il~ size 1~ x lO x 2 mln were used as su~ates. Ihc two-step l-c ~ 1 and y~ ;r~\tiQn weFc ~.ron~ the m~ls ~s d ~ s e "1~ 3. Ihe ~ ratcd r91- ;r.~ -- 60lUtioD used fa~ ~crsion was y~ U~
0 by d;5sol~ u~g O~9~o BSA into 0.8 ACS. ~11 the samples we~e im~e~cd in 37~C water-bath for nvo days.
I~elcas~ c~peruncn~s ~he BSA contcnt in solution was measured by mcans of total organic carbon (TOC~)me~od. Four blocks w~th Ca-P/BSA roa~in~c were compl~tely diss~lved by 40 ml of 05 ~ HCI solution to d~tect thc ~ tiO1~ of BSA in Ca-PlBSA coat~n~ Four . were i,~ ,d in 20 ml of 0.01 M PBS at pH 4 (adjustcd Usi~lg Ha) at 37~C.
At ccrtain interval6 of time, 5 ml of the i~ solll~ion was takcn for TOC
meas~lc~"t at ccltain ~nterval and then ref~ll to 20 ml ~ith new E'BS at pH 4 evcry time.
ZO R~su~
B54 co/~ tion in C~-P/~ coanng ~he Ca-P/BS~ coatings on five sample~ w~e peded off complctcly and then ~ v;gh~
using a bsll~n~c The weight of the Ca-P/BSA coati~ on each samplc can bc ~
to be a mcsn of 15 mg. The ca~bon ~.- - --t,~ in tbe coating was r~J~ ~ to be 15 % and thc BSA ~c~ ti~ was about 30% be~use thc carbon ~ r~ ti~A i~
BSA was ~l~t~t~d to be around 50% by thc same method.
BS~ ~leasc cun~e T~C a~ount of BSA ~ s~ into PBS was plotted agaillst tbc ;..~ time as shown m Flgurc 17. It is ~dicated that undcr thcsc c ..~ ditions, BSA was, ..l~s 30 ,~il~ti~ tast m thc first two days of the ~ n and the~ thc n:lease latc lcvcllcd off so~ . Thc main reason could be that thc PBS was very acidic ~H - 4) at tbc b~ e stage and the coating was diss~l~cd vcry fast. After certain time of i.. ..the pH bcc~nc bighcr. Thc pH values of PBS at thc 7th and 14th were ~ s~ ~ to be 1~041299 CA 02205104 1997-05-22 ~3 ;

5.628 aDd ~.S84".i~ . p~ ~ t~ese rcsults to the act~al in vivo s;~
where tbe pH valuc will be around 7, these Iesults indicatc that a dual, slow ~elease sy~tam ~s obt~ ssuming that t~e 48 hours ~DcuWon in ~m ~cidic ~Ai~
comparable to 6cvc~al weeks, if not months impl~tation in a C~ r--Ihis c~mel~t shaw~ that p~otems such a6 BSA ca~l be co ~r~ A in a calcium phos~atc coa~g ;md that it ca~ r~ Al~ be le~ d ~om thc coatiI~g. ~
BSA was uscd to ~.~,.",;~r, the fC~ jlity of ~his techniquc, it is clear that a Ca-Ph -'~ 'ly ac~ve agent c~ coating can be used as sort of a dmg deliv~y 10 system and bas lh_.efo,G ,x ~s lti~l ~n the mcdical field.

Iable 1- Su~ce ~ou~uc~ xs~

SuIfa¢e fiIIisbl Ra (~Im) Rz (~m) ~ (llm) 1-4V 1200 grit 0.47 ~ 0.01 3.74:1;0.04 5.13 ~ 0.08 6Al-4V4000grit 0.24~0.03 1.91_0.~1 2.4~054 Ti-6AI-4V 1 llm 0.03+0.00 0 ~5 ~ o.n~ 0.48~0.03 Ti~ 2.5Fe 1200 gnt 0.42~0.03 2.97~0.35 3.47~0A8 Ti-AI-2.5F~ 4000 gnt 0 ~.3+0 01 1.97 ~ 0.18 2.46~0.34 Ti-AI-25Fc 1 llm 0.04_0.01 0.~&0.11 0.36_0.19.
316 L 1200 gnt 0.3 ~ 0.06 2.32~0.47 2.96:~:0.03 2~ 316 L4000 ~nt ~ 01 0.35_0.1 0.46~0.1 Table 2 - Iist of Ca2+ a~ld HPO4~ c~l.it~jo~ rate a~d c- vl - ' of Ca-P coatings on cp.Ti a~d Ti6A14V.

Concentration (m~ Ca2+ 3.0 1.26 HPO 2- 1.87 0.78 Prccipitation rate ofNo P~C~ 0.5 ~hr 1 ~wk coat~g Prc-Ca 1 ~r 3 l~/wlc n of coa~i~g apatitc, OCP apatitc 1~0 41~99 CA 02205104 1997-05-22 l~lgore c-ptiou5 Figuse 1--Ca conce~tian as a R.--r I ;- -. of time ~gu~e 2--P c ~--r~ aS a fi~ tinn of t~ne Figu~e 3 - SEM photan~ctogtaphs of the maal sur~ces after Lmma~iion m EIBSS. A:
~ 4V 1200; B~ 4V 4000; C: r~ 4V 1 ~; D~ 25Fc 1 ,um; E: rl-Al-2~Fe 4000; F- st~inle~s steel lW
Pigurc 4 - AFM ~\h~ a~h of a n~ 25Fe 1 ~lm sample a~t~; ~ ~ Q~
HBSS. I~c~easillg ~na~~ h~ from ficld O to 3. Sc~mi~g le~ ~om field 3: 15 ~m.
lo Figure S - XRMA spec~ cd on z 1~-6A1 4V 4000 sample be*~e (A) and &
~e~;sion (B) in H~SS.
F~c 6 - ~ pcctra a~ d on a "o~ r~C~,d (A) u~d imme~ (B) 1~-6AI-~V 1 llm surface Figure 7. Surface ch~ os;l io (iD atomic percent) of tbe "as ~ coating.
15 Figure 8. ~epth profile of the coating, ~om coating to substrate.
E;igure 9. Sca~ing electron ".ic~o~; ~h of the Ca-P u~ating (C~ p~ecipitated on cp.Ti cr~) a~ter 16 hours of; -- ~ A ~;OJ) in F~ vith Pre-Ca.
Fig~c 10. ED~ spectra of t~ cp.Ti surfaces non-treated, treated and i~ ?A m E~CSwith Pre-Ca for dir~ t hou~s. The choulder of O ka pcak is clearly secn 2~ after the ~-A~ l The Ca and p rr"~t~.. h, iuclG.~3~,d ~ith ~be inclc--- of ~ersion time.
Fi~e 11. X~ pattems of thc c~.Ti surfac~s afte~ di~ nl houIs of ;~ in FCS
with Pre-Ca. Tbc count~ of apatite peaks get bigher l~vith incrcased i..~
times. Oc~a-calcium ~ (OCP) starts to bc fo~med at around 8 houls.
~5 ~ue 1~ Scannin~ clectron ~ic.~,, . } of a de~e Ca-P coa~ng (CP) p. ~ ~ ' on cp.Ti ~om HBSS after 1 week of ;"~ r.~ vith Pre-Ca The layer b~h._aA
coating and ~ C~tC iS t~c titanium o~nde layer (OL), fonncd ss a result of the t~eatment. ~ote the surface roughness of thc implant on which the calcium phosphate coating bas bccn formed.
~0 Fgure 13. Thin-film XRD pattern of a dalse Ca-P coating ~ I by immcrsion in HBSS with P~-Ca ~ veek.
Figme 14. ~ elec~.o~ ~nicrograph of po~ous ~ ~a) aftcr 2 days ;- ~ e.~ . in FCS wit~ Pre-Ca. ~hc coating is fonncd thro~E h~t thc porous 1~ 1 ~04~ CA 02205l04 l997-05-22 F~e 15. EDX spcctr~ of (a) non-trca~d, (b) t~ed, a~d (c) Prc-Ca trca~cd, 2 day FCS i~ porou6~ a) s~nplc.
~i~ue 16. IR ~pectra of BSA (a) and ~p.n surfaces afte~ 2 days of ;----- "cj~
CrJJ~ , 02%~vt. BS~ d E:CS only (c). ~e cSi6teDcc of four s ab~ ~tio . ba~s of BSA in ~ s thc c, ~ n of BSA
~Rith tbc biomimedc calaum p~D~p.~te coati~g.
F~e 17. Thc amou~t of ~SA released into P~ as a result of ~c ;~ -- e.~ on t~e Liter~ture ~treDces 1. Y. F~ishiro, T. Sato and A. Ohlwalci, "Coa~g of h~J~u.~ , ou mehl plates 0 ~g thc~mal dissûciation of ~Icium -I~DTA chelate in F~k~~ t~ so~ ~l:n ,~ under h,~ hr- ~-~9~ jl ;n~.c", J. h~te~. Sc: Mater in Ucd, 6, pp. 172-176, 1995 2. S.R Radin and P. D~ , J. Bion~ Mater. Kes." 27, pp. 35, 19~3 3. T. Ha~avv~, "Titsnium a~ld its o~dc film: a r~ ,t for fo~ming apatite", in Proc.
of thc Bone }~ ' al Intcrfsce ~V~n~ n~, To~ to, Dec. 199~ J.~. Davies ed., Univ. Toronto P~css, pp. 49-61,1991 4. Ii, P, P~D. thesis Lcidcn U~u~J~Sit~ (1993) 5. P. D~ , S. Radin and K. ~ ikawa, ' The ratc of calciu~ ~
o~ on metal aPd cc.~i~, aDd ~c rrl tiQ~-h;l~ to bioactivity", in Bonc ~ Ai~ n~ ;9~S, p. D~ .e, T. ~okubo & CA, va~ Blitte~svrijk (eds), Rccd H~71thr~ m~nic~atio~ pp. 213-21~ 1992.

Claims (10)

1. An implantable device of a material having a surface roughness with an average peak distance (Ra value) between 10 and 1,000 nm, said surface being coated with a layer comprising calcium ions and phosphate ions.
2. An implantable device according to claim 1, wherein said layer further comprises a growth factor, a lipid, a (lipo)polysaccharide, a cytostatic agent, a hormone, an antibiotic, a protein and/or another biologically active agent.
3. An implantable device according to claim 1 or 2, having a surface roughness with an average depth between 20 and 1,000 nm.
4. An implantable device according to any one of claims 1-3, wherein said layer of calcium phosphate has a thickness of 50 nm - 200 µm, in particular of between 1000 nm and 50 µm.
5. An implantable device according to any one of claims 1-4, wherein said material is a metal, a metal alloy, a ceramic material, a natural or synthetic polymer or a composite of any of these materials.
6. A process for producing an implantable device, comprising subjecting a porous or non-porous material to a surface treatment until a surface roughness with an average peak distance (Ra value) between 10 and 1,000 nm is obtained, and subsequently subjecting the surface to precipitation of calcium phosphate from a solution containing calcium and phosphate ions.
7. A process according to claim 6, wherein said solution has a pH of 4-10, preferably 6-8.
8. A process according to claim 6 or 7, wherein said solution further contains agrowth factor, a lipid, a (lipo)polysaccharide, a hormone, a cytostatic agent, an antibiotic, a protein and/or another biologically active agent.
9. A process according to any one of claims 6-8, wherein said subjecting to precipitation of calcium phosphate is carried out in two stages.
10. Use of a device according to any one of claims 1-5, or produced according to any one of claims 6-9, as a bone substituted, a joint prosthesis, a dental implant, a maxillofacial implant, a vertebral surgery aid, a transcutaneous device or any other hard-tissue-related device.
CA002205104A 1996-05-10 1997-05-12 Device for incorporation and release of biologically active agents Abandoned CA2205104A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201293.6 1996-05-10
EP96201293 1996-05-10

Publications (1)

Publication Number Publication Date
CA2205104A1 true CA2205104A1 (en) 1997-11-10

Family

ID=8223977

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002205107A Abandoned CA2205107A1 (en) 1996-05-10 1997-05-12 Implant material and process for producing it
CA002205104A Abandoned CA2205104A1 (en) 1996-05-10 1997-05-12 Device for incorporation and release of biologically active agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002205107A Abandoned CA2205107A1 (en) 1996-05-10 1997-05-12 Implant material and process for producing it

Country Status (5)

Country Link
US (2) US6069295A (en)
AT (2) ATE235927T1 (en)
CA (2) CA2205107A1 (en)
DE (2) DE69716505T2 (en)
ES (2) ES2196252T3 (en)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6491723B1 (en) * 1996-02-27 2002-12-10 Implant Innovations, Inc. Implant surface preparation method
US6652765B1 (en) * 1994-11-30 2003-11-25 Implant Innovations, Inc. Implant surface preparation
US5863201A (en) * 1994-11-30 1999-01-26 Implant Innovations, Inc. Infection-blocking dental implant
BR9509934A (en) * 1994-11-30 1998-01-27 Implant Innovations Inc Preparation of implant surface
AU736216B2 (en) * 1997-03-27 2001-07-26 Smith & Nephew, Inc. Method of surface oxidizing zirconium alloys and resulting product
SE9701647D0 (en) * 1997-04-30 1997-04-30 Nobel Biocare Ab Calcium-phonsphate coated implant element
ES2196717T3 (en) * 1998-09-15 2003-12-16 Isotis Nv METHOD FOR COATING MATERIALS OF MEDICAL IMPLANTS.
JP3072373B1 (en) * 1999-07-05 2000-07-31 工業技術院長 Artificial dental root having pollutant, germ adhesion suppressing function and acid resistance, and manufacturing method
US20060194008A1 (en) * 1999-09-22 2006-08-31 Princeton University Devices with multiple surface functionality
US6610067B2 (en) 2000-05-01 2003-08-26 Arthrosurface, Incorporated System and method for joint resurface repair
US8012590B2 (en) 2000-05-01 2011-09-06 The Regents Of The University Of California Glass/ceramic coatings for implants
EP2314257B9 (en) 2000-05-01 2013-02-27 ArthroSurface, Inc. System for joint resurface repair
US6805898B1 (en) * 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
US7083642B2 (en) * 2000-12-22 2006-08-01 Avantec Vascular Corporation Delivery of therapeutic capable agents
US6599322B1 (en) 2001-01-25 2003-07-29 Tecomet, Inc. Method for producing undercut micro recesses in a surface, a surgical implant made thereby, and method for fixing an implant to bone
US6620332B2 (en) * 2001-01-25 2003-09-16 Tecomet, Inc. Method for making a mesh-and-plate surgical implant
US7018418B2 (en) * 2001-01-25 2006-03-28 Tecomet, Inc. Textured surface having undercut micro recesses in a surface
JP2002322013A (en) * 2001-04-25 2002-11-08 Univ Nagoya Precursor of active substance, active substance produced by using the precursor, and method for producing the active substance
US7695521B2 (en) 2001-05-01 2010-04-13 Amedica Corporation Hip prosthesis with monoblock ceramic acetabular cup
US7776085B2 (en) * 2001-05-01 2010-08-17 Amedica Corporation Knee prosthesis with ceramic tibial component
US20050177238A1 (en) * 2001-05-01 2005-08-11 Khandkar Ashok C. Radiolucent bone graft
EP1408874B1 (en) * 2001-06-14 2012-08-08 Amedica Corporation Metal-ceramic composite articulation
SE519531C2 (en) * 2001-07-04 2003-03-11 Nobel Biocare Ab Implants including pore arrangements coated with calcium phosphate
JP4347044B2 (en) * 2001-07-26 2009-10-21 アバンテク バスキュラー コーポレーション Device for delivering a therapeutic agent having a variable release profile
BR0214275A (en) 2001-11-19 2004-09-21 Scil Technology Gmbh Device having osteoconductive and osteoinductive properties
WO2003072496A1 (en) * 2002-02-26 2003-09-04 Hyun-Man Kim Calcium phosphate colloids, dots, islands, thin films or granules and its preparation
EP1358859A1 (en) * 2002-04-29 2003-11-05 Politecnico Di Milano Bone prostheses having multilayer interface
GB0210786D0 (en) * 2002-05-10 2002-06-19 Plasma Coatings Ltd Orthopaedic and dental implants
US6794273B2 (en) * 2002-05-24 2004-09-21 Fujitsu Limited Semiconductor device and manufacturing method thereof
WO2010096826A1 (en) * 2002-06-04 2010-08-26 Arthrosurface Incorporated Nanorough alloy substrate
SE523236C2 (en) * 2002-07-19 2004-04-06 Astra Tech Ab An implant and a method of treating an implant surface
SE523288C2 (en) * 2002-07-19 2004-04-06 Astra Tech Ab An implant and a method of treating an implant surface
ES2260685T3 (en) * 2002-09-10 2006-11-01 Scil Technology Gmbh METALLIC IMPLANT COVERED, TO A REDUCED OXYGEN CONCENTRATION, WITH OSTEOINDUCTING PROTEIN.
AU2003297195A1 (en) * 2002-12-17 2004-07-22 Amedica Corporation Total disc implant
US20040167632A1 (en) * 2003-02-24 2004-08-26 Depuy Products, Inc. Metallic implants having roughened surfaces and methods for producing the same
US8388624B2 (en) 2003-02-24 2013-03-05 Arthrosurface Incorporated Trochlear resurfacing system and method
GB0304168D0 (en) * 2003-02-24 2003-03-26 Benoist Girard Sas Surface treatment of metal
US8251700B2 (en) * 2003-05-16 2012-08-28 Biomet 3I, Llc Surface treatment process for implants made of titanium alloy
US7067169B2 (en) * 2003-06-04 2006-06-27 Chemat Technology Inc. Coated implants and methods of coating
US20040267376A1 (en) * 2003-06-25 2004-12-30 Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel, Ltd) Ceramic member for medical implant and its production method
US7419680B2 (en) * 2003-10-01 2008-09-02 New York University Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate
US9199005B2 (en) * 2003-10-01 2015-12-01 New York University Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate
EP1529497B1 (en) * 2003-11-04 2009-10-28 Friadent GmbH Dental implant component
EP1529498B9 (en) * 2003-11-05 2014-09-10 Dentsply Implants Manufacturing GmbH Multi part non metal implant
US7981461B2 (en) * 2004-01-30 2011-07-19 Georgette Frederick S Metallic bone implant having improved implantability and method of making the same
AU2005260590A1 (en) 2004-06-28 2006-01-12 Arthrosurface, Inc. System for articular surface replacement
SE530060C2 (en) * 2004-09-01 2008-02-19 Nobel Biocare Ab Implants for dental prosthetics and the procedure and systems for making the implant
US7473278B2 (en) * 2004-09-16 2009-01-06 Smith & Nephew, Inc. Method of surface oxidizing zirconium and zirconium alloys and resulting product
US8750983B2 (en) 2004-09-20 2014-06-10 P Tech, Llc Therapeutic system
US7785648B2 (en) * 2004-09-22 2010-08-31 New York University Adherent apatite coating on titanium substrate using chemical deposition
US7235592B2 (en) * 2004-10-12 2007-06-26 Zimmer Gmbh PVA hydrogel
WO2006050365A2 (en) * 2004-10-28 2006-05-11 The Regents Of The University Of Michigan Methods for production of synthetic hydroxyapatite nanorods
US20060184251A1 (en) * 2005-01-07 2006-08-17 Zongtao Zhang Coated medical devices and methods of making and using
JP2008531769A (en) 2005-02-23 2008-08-14 ズィマー・テクノロジー・インコーポレーテッド Blend hydrogel and method for producing the same
EP1853394A4 (en) * 2005-02-24 2009-09-30 Biomet 3I Llc Surface treatment methods for implants made of titanium or titanium alloy
CN101180404A (en) * 2005-04-22 2008-05-14 杂混复合塑料公司 Biomimetic materials comprising polyhedral oligomeric silsesquioxanes
US7901462B2 (en) * 2005-06-23 2011-03-08 Depuy Products, Inc. Implants with textured surface and methods for producing the same
US7571295B2 (en) * 2005-08-04 2009-08-04 Intel Corporation Memory manager for heterogeneous memory control
US20070098799A1 (en) * 2005-10-28 2007-05-03 Zimmer, Inc. Mineralized Hydrogels and Methods of Making and Using Hydrogels
KR101369388B1 (en) * 2005-11-14 2014-03-06 바이오메트 쓰리아이 엘엘씨 Deposition of discrete nanoparticles on an implant surface
CA2632120C (en) * 2005-12-07 2014-07-08 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation
ES2606666T3 (en) * 2005-12-15 2017-03-27 Smith & Nephew, Inc. Medical implant hardened by diffusion
US20070141108A1 (en) * 2005-12-20 2007-06-21 Zimmer, Inc. Fiber-reinforced water-swellable articles
US8017107B2 (en) * 2005-12-22 2011-09-13 Zimmer, Inc. Perfluorocyclobutane crosslinked hydrogels
US8252058B2 (en) * 2006-02-16 2012-08-28 Amedica Corporation Spinal implant with elliptical articulatory interface
US20070198093A1 (en) * 2006-02-17 2007-08-23 Amedica Corporation Spinal implant with offset keels
US8110242B2 (en) * 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
EP1847278A1 (en) * 2006-04-13 2007-10-24 Camlog Biotechnologies AG Bio-dissolvable salt coatings of implants for the protection against organic impurities
US20080069854A1 (en) * 2006-08-02 2008-03-20 Inframat Corporation Medical devices and methods of making and using
CN101588826A (en) * 2006-08-02 2009-11-25 英孚拉玛特公司 Lumen-supporting devices and methods of making and using
NO20064595A (en) * 2006-10-10 2008-03-17 Roella Gunnar Titanium implant and method of making the same
ES2729425T3 (en) * 2006-10-24 2019-11-04 Biomet 3I Llc Deposition of discrete nanoparticles on a nanostructured surface of an implant
AU2007332787A1 (en) 2006-12-11 2008-06-19 Arthrosurface Incorporated Retrograde resection apparatus and method
KR100930279B1 (en) * 2007-06-20 2009-12-09 재단법인서울대학교산학협력재단 Calcium Phosphate Ultra Thin Films and Preparation Method thereof
US20090008365A1 (en) * 2007-07-06 2009-01-08 Depuy Products, Inc. Microtextured Implants and Methods of Making Same
EP2022447A1 (en) 2007-07-09 2009-02-11 Astra Tech AB Nanosurface
KR100775537B1 (en) * 2007-07-19 2007-11-28 (주)오스테오필 Method of fabricating implant with improved surface properties and implant fabiricated by the same method
US7731988B2 (en) 2007-08-03 2010-06-08 Zimmer, Inc. Multi-polymer hydrogels
US20090036996A1 (en) * 2007-08-03 2009-02-05 Roeber Peter J Knit PTFE Articles and Mesh
US20090187197A1 (en) * 2007-08-03 2009-07-23 Roeber Peter J Knit PTFE Articles and Mesh
US20090043398A1 (en) * 2007-08-09 2009-02-12 Zimmer, Inc. Method of producing gradient articles by centrifugation molding or casting
US8062739B2 (en) * 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US7947784B2 (en) * 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces
ES2545781T3 (en) * 2008-01-28 2015-09-15 Biomet 3I, Llc Superficial implant with greater hydrophilicity
US8361381B2 (en) 2008-09-25 2013-01-29 Smith & Nephew, Inc. Medical implants having a porous coated surface
US9592043B2 (en) * 2009-03-31 2017-03-14 Covidien Lp Multizone implants
US20100268227A1 (en) 2009-04-15 2010-10-21 Depuy Products, Inc. Methods and Devices for Bone Attachment
US8696759B2 (en) 2009-04-15 2014-04-15 DePuy Synthes Products, LLC Methods and devices for implants with calcium phosphate
AU2010236182A1 (en) 2009-04-17 2011-11-24 Arthrosurface Incorporated Glenoid resurfacing system and method
WO2016154393A1 (en) 2009-04-17 2016-09-29 Arthrosurface Incorporated Glenoid repair system and methods of use thereof
US9662126B2 (en) 2009-04-17 2017-05-30 Arthrosurface Incorporated Glenoid resurfacing system and method
US8475536B2 (en) * 2010-01-29 2013-07-02 DePuy Synthes Products, LLC Methods and devices for implants with improved cement adhesion
AU2011222404A1 (en) 2010-03-05 2012-09-27 Arthrosurface Incorporated Tibial resurfacing system and method
US8641418B2 (en) 2010-03-29 2014-02-04 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
TWI543754B (en) * 2010-06-24 2016-08-01 Univ Kaohsiung Medical Surface treatment of dental implants with tissue integration
DE102010025533B4 (en) 2010-06-29 2014-09-04 Heraeus Medical Gmbh Procedure for bone growth promoting coating
US9381112B1 (en) 2011-10-06 2016-07-05 William Eric Sponsell Bleb drainage device, ophthalmological product and methods
US8632489B1 (en) 2011-12-22 2014-01-21 A. Mateen Ahmed Implantable medical assembly and methods
WO2013096746A1 (en) 2011-12-22 2013-06-27 Arthrosurface Incorporated System and method for bone fixation
US9131995B2 (en) 2012-03-20 2015-09-15 Biomet 3I, Llc Surface treatment for an implant surface
WO2014008126A1 (en) 2012-07-03 2014-01-09 Arthrosurface Incorporated System and method for joint resurfacing and repair
US9492200B2 (en) 2013-04-16 2016-11-15 Arthrosurface Incorporated Suture system and method
US11607319B2 (en) 2014-03-07 2023-03-21 Arthrosurface Incorporated System and method for repairing articular surfaces
US10624748B2 (en) 2014-03-07 2020-04-21 Arthrosurface Incorporated System and method for repairing articular surfaces
US9861492B2 (en) 2014-03-07 2018-01-09 Arthrosurface Incorporated Anchor for an implant assembly
EP3685866B1 (en) * 2014-05-02 2023-08-09 The Royal Institution for the Advancement of Learning / McGill University Structural porous biomaterial and implant formed of same
US20150366668A1 (en) * 2014-06-23 2015-12-24 Community Blood Center Cellular-scale surface modification for increased osteogenic protein expression
CN108096640A (en) * 2016-11-24 2018-06-01 重庆润泽医药有限公司 A kind of porous material
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same
US11160663B2 (en) 2017-08-04 2021-11-02 Arthrosurface Incorporated Multicomponent articular surface implant
GB2596006B (en) 2019-03-12 2022-11-30 Arthrosurface Inc Humeral and glenoid articular surface implant systems and methods

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984914A (en) * 1974-07-24 1976-10-12 Robert Schwartz Oral implant
JPS5214095A (en) * 1975-07-23 1977-02-02 Sumitomo Chemical Co Implant in bone
US4687487A (en) * 1978-07-21 1987-08-18 Association Suisse Pour La Recherches Horlogere Joint implant
SE416175B (en) * 1979-03-07 1980-12-08 Per Ingvar Branemark FOR IMPLANTATION IN BODY TISSUE Separate Bone Tissue, Dedicated Material
DE3223925C2 (en) * 1982-06-26 1986-07-31 Feldmühle AG, 4000 Düsseldorf Implantable elbow joint
GB8318483D0 (en) * 1983-07-08 1983-08-10 Zimmer Deloro Surgical Ltd Skeletal implants
US4636526A (en) * 1985-02-19 1987-01-13 The Dow Chemical Company Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics
FR2585576B1 (en) * 1985-07-30 1992-01-03 Bioetica Sa BONE MATRIX REPLACEMENT PROMOTING OSTEOGENESIS
JPH0669482B2 (en) * 1985-08-08 1994-09-07 住友化学工業株式会社 Intraosseous implant manufacturing method
US4818559A (en) * 1985-08-08 1989-04-04 Sumitomo Chemical Company, Limited Method for producing endosseous implants
DD246028A1 (en) * 1986-02-12 1987-05-27 Karl Marx Stadt Tech Hochschul CERAMIZED METAL IMPLANT
GB2189815B (en) * 1986-03-24 1990-10-10 Permelec Electrode Ltd Titanium composite materials coated with calcium phosphate compound and process for production thereof
US5344457A (en) * 1986-05-19 1994-09-06 The University Of Toronto Innovations Foundation Porous surfaced implant
JPS6399867A (en) * 1986-10-17 1988-05-02 ペルメレツク電極株式会社 Composite material coated with calcium phosphate and its production
US4879136A (en) * 1987-02-24 1989-11-07 Dentsply G.M.B.H. Method of applying opaque dental ceramic material to a metal structure
JPS6486975A (en) * 1987-09-29 1989-03-31 Permelec Electrode Ltd Preparation of calcium phosphate compound coated composite material
DE3865421D1 (en) * 1987-12-23 1991-11-14 Sumitomo Chemical Co COATING LIQUID CONTAINING HYDROXYAPATITE AND METHOD FOR PRODUCING A HYDROXYAPATITE COVER USING THE SAME.
US5180426A (en) * 1987-12-28 1993-01-19 Asahi Kogaku Kogyo K.K. Composition for forming calcium phosphate type setting material and process for producing setting material
US4880610A (en) * 1988-04-20 1989-11-14 Norian Corporation In situ calcium phosphate minerals--method and composition
US5219361A (en) * 1988-09-16 1993-06-15 Clemson University Soft tissue implant with micron-scale surface texture to optimize anchorage
EP0388576B1 (en) * 1989-03-23 1993-09-15 Institut Straumann Ag Metallic implant
JP2830262B2 (en) * 1990-01-08 1998-12-02 住友化学工業株式会社 Method for forming hydroxyapatite film
US5164187A (en) * 1990-04-05 1992-11-17 Norian Corporation Hydroxyapatite prosthesis coatings
JP2978203B2 (en) * 1990-04-20 1999-11-15 日本特殊陶業株式会社 Method for producing ceramic body having bioactive surface layer
SE468153B (en) * 1990-10-08 1992-11-16 Astra Meditec Ab SET FOR TREATMENT OF TITAN OR TITAN ALLOY IMPLANT
US5205921A (en) * 1991-02-04 1993-04-27 Queen's University At Kingston Method for depositing bioactive coatings on conductive substrates
US5478237A (en) * 1992-02-14 1995-12-26 Nikon Corporation Implant and method of making the same
US5358529A (en) * 1993-03-05 1994-10-25 Smith & Nephew Richards Inc. Plastic knee femoral implants
NL9301941A (en) * 1993-11-09 1995-06-01 Klaas De Groot Method of applying a coating of a bioactive material to implants.
US5607480A (en) * 1993-11-10 1997-03-04 Implant Innovations, Inc. Surgically implantable prosthetic devices
US5947893A (en) * 1994-04-27 1999-09-07 Board Of Regents, The University Of Texas System Method of making a porous prothesis with biodegradable coatings
BR9509934A (en) * 1994-11-30 1998-01-27 Implant Innovations Inc Preparation of implant surface
WO1996039202A1 (en) * 1995-06-06 1996-12-12 Osteogenics Inc. Biocompatible hydroxyapatite formulations and uses therefor
JPH0956805A (en) * 1995-08-24 1997-03-04 Millennium Biologics Inc Improved sintering method for thin film manufacturing of calcium phosphate material
US5730598A (en) * 1997-03-07 1998-03-24 Sulzer Calcitek Inc. Prosthetic implants coated with hydroxylapatite and process for treating prosthetic implants plasma-sprayed with hydroxylapatite

Also Published As

Publication number Publication date
DE69716505D1 (en) 2002-11-28
ATE235927T1 (en) 2003-04-15
DE69716505T2 (en) 2003-06-26
US6146686A (en) 2000-11-14
ATE226453T1 (en) 2002-11-15
US6069295A (en) 2000-05-30
DE69720316T2 (en) 2004-04-01
CA2205107A1 (en) 1997-11-10
DE69720316D1 (en) 2003-05-08
ES2196252T3 (en) 2003-12-16
ES2185861T3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
CA2205104A1 (en) Device for incorporation and release of biologically active agents
Yan et al. Apatite layer-coated titanium for use as bone bonding implants
de Bruijn et al. Structural arrangements at the interface between plasma sprayed calcium phosphates and bone
Porter et al. The ultrastructure of the plasma-sprayed hydroxyapatite–bone interface predisposing to bone bonding
Tisdel et al. The influence of a hydroxyapatite and tricalcium-phosphate coating on bone growth into titanium fiber-metal implants.
Atlan et al. Interface between bone and nacre implants in sheep
Søballe Hydroxyapatite ceramic coating for bone implant fixation: mechanical and histological studies in dogs
Cook et al. Hydroxylapatite coating of porous implants improves bone ingrowth and interface attachment strength
Tanahashi et al. Apatite coated on organic polymers by biomimetic process: Improvement in its adhesion to substrate by glow‐discharge treatment
US20190374677A1 (en) Modified surfaces for attachment of biological materials
Morscher Current status of acetabular fixation in primary total hip arthroplasty.
LENNOX et al. A histologic comparison of aseptic loosening of cemented, press-fit, and biologic ingrowth prostheses
Søballe et al. Tissue ingrowth into titanium and hydroxyapatite‐coated implants during stable and unstable mechanical conditions
Soballe et al. Hydroxyapatite coating converts fibrous tissue to bone around loaded implants
Liu et al. Surface modification of titanium, titanium alloys, and related materials for biomedical applications
Morrison et al. In vitro biocompatibility testing of polymers for orthopaedic implants using cultured fibroblasts and osteoblasts
Müller‐Mai et al. Nanoapatite and organoapatite implants in bone: histology and ultrastructure of the interface
Tanahashi et al. Ultrastructural study of an apatite layer formed by a biomimetic process and its bonding to bone
Bobyn et al. Human histology of the bone-porous metal implant interface
EP2251049A2 (en) Methods and devices for bone attachment
Bloebaum et al. Postmortem comparative analysis of titanium and hydroxyapatite porous-coated femoral implants retrieved from the same patient: a case study
Clemens et al. Healing of gaps around calcium phosphate‐coated implants in trabecular bone of the goat
Orr et al. Scanning electron microscopy of the bone interface with titanium, titanium alloy and hydroxyapatite
EP2071916A1 (en) Bio active ceramic coatings with excellent bio-compatibility and preaparation method thereof
CA2091078C (en) Surface coating for prothesis system

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued